Literature DB >> 14757696

Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase.

Mohit Jain1, Lei Cui, Daniel A Brenner, Bo Wang, Diane E Handy, Jane A Leopold, Joseph Loscalzo, Carl S Apstein, Ronglih Liao.   

Abstract

BACKGROUND: Free radical injury contributes to cardiac dysfunction during ischemia-reperfusion. Detoxification of free radicals requires maintenance of reduced glutathione (GSH) by NADPH. The principal mechanism responsible for generating NADPH and maintaining GSH during periods of myocardial ischemia-reperfusion remains unknown. Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in the pentose phosphate pathway, generates NADPH in a reaction linked to the de novo production of ribose. We therefore hypothesized that G6PD is essential for maintaining GSH levels and protecting the heart during ischemia-reperfusion injury. METHODS AND
RESULTS: Susceptibility to myocardial ischemia-reperfusion injury was determined in Langendorff-perfused hearts isolated from wild-type mice (WT) and mice lacking G6PD (G6PD(def)) (20% of WT myocardial G6PD activity). During global zero-flow ischemia, cardiac function was similar between WT and G6PD(def) hearts. On reperfusion, however, cardiac relaxation and contractile performance were greatly impaired in G6PD(def) myocardium, as demonstrated by elevated end-diastolic pressures and decreased percent recovery of developed pressure relative to WT hearts. Contractile dysfunction in G6PD(def) hearts was associated with depletion of total glutathione stores and impaired generation of GSH from its oxidized form. Increased ischemia-reperfusion injury in G6PD(def) hearts was reversed by treatment with the antioxidant MnTMPyP but unaffected by supplementation of ribose stores.
CONCLUSIONS: These results demonstrate that G6PD is an essential myocardial antioxidant enzyme, required for maintaining cellular glutathione levels and protecting against oxidative stress-induced cardiac dysfunction during ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757696     DOI: 10.1161/01.CIR.0000112605.43318.CA

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure?

Authors:  Mirit Eynan; Dimitry Tsitlovsky; Liron Batit; Ayala Hochman; Nitzan Krinsky; Amir Abramovich
Journal:  Eur J Appl Physiol       Date:  2011-11-11       Impact factor: 3.078

2.  The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.

Authors:  Rachit Badolia; Dinesh K A Ramadurai; E Dale Abel; Peter Ferrin; Iosif Taleb; Thirupura S Shankar; Aspasia Thodou Krokidi; Sutip Navankasattusas; Stephen H McKellar; Michael Yin; Abdallah G Kfoury; Omar Wever-Pinzon; James C Fang; Craig H Selzman; Dipayan Chaudhuri; Jared Rutter; Stavros G Drakos
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

3.  Innate short-circuiting of mitochondrial metabolism in cardiac hypertrophy: identification of novel consequences of enhanced anaplerosis.

Authors:  Michael N Sack
Journal:  Circ Res       Date:  2009-03-27       Impact factor: 17.367

Review 4.  The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.

Authors:  M M C Wamelink; E A Struys; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2008-11-08       Impact factor: 4.982

5.  Oxidoreductase regulation of Kv currents in rat ventricle.

Authors:  Huixu Liang; Xun Li; Shumin Li; Ming-Qi Zheng; George J Rozanski
Journal:  J Mol Cell Cardiol       Date:  2008-03-28       Impact factor: 5.000

Review 6.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 7.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

Review 8.  Responses to reductive stress in the cardiovascular system.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2016-12-08       Impact factor: 7.376

9.  Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Authors:  Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

Review 10.  Cellular metabolic and autophagic pathways: traffic control by redox signaling.

Authors:  Matthew Dodson; Victor Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2013-05-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.